RE:RE:RE:RE:RE:Gap Open @ C$ 1.86Lottsa room for one or two with 2 and potentially 3 registration studies now being pursued both in monotherapy and in combination with other I/O agents. The monotherapy registration study offers ONCY the freedom to operate and removes any restriction for the company to partner with one Big Pharma company or another.